about
Inactivation of a novel FGF23 regulator, FAM20C, leads to hypophosphatemic rickets in miceFGF23 and Phosphate Wasting DisordersNuclear receptors in bone physiology and diseasesGenetic disorders of phosphate regulationPhosphate homeostasis and its role in bone healthProteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemiaNHE3 regulatory factor 1 (NHERF1) modulates intestinal sodium-dependent phosphate transporter (NaPi-2b) expression in apical microvilliThe Role and Potential Therapeutic Implications of the Fibroblast Growth Factors in Energy Balance and Type 2 Diabetes.Adverse effects of simulated hyper- and hypo-phosphatemia on endothelial cell function and viability.Effect of paricalcitol on circulating parathyroid hormone in X-linked hypophosphatemia: a randomized, double-blind, placebo-controlled studyA low fractional excretion of Phosphate/Fgf23 ratio is associated with severe abdominal Aortic calcification in stage 3 and 4 kidney disease patients.Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysisA clinician's guide to X-linked hypophosphatemiaArterial calcification and bone physiology: role of the bone-vascular axis.Ablation of the Stimulatory G Protein α-Subunit in Renal Proximal Tubules Leads to Parathyroid Hormone-Resistance With Increased Renal Cyp24a1 mRNA Abundance and Reduced Serum 1,25-Dihydroxyvitamin D.Nutrition in Cardioskeletal Health.The hypoxia-inducible factor-1α activates ectopic production of fibroblast growth factor 23 in tumor-induced osteomalacia.Clinical practice. Fibroblast growth factor (FGF)23: a new hormone.The skeleton as an endocrine organ.The SLC34 family of sodium-dependent phosphate transporters.Renal handling of phosphate and sulfate.Hypophosphatemic rickets: etiology, clinical features and treatment.Regulation of renal phosphate handling: inter-organ communication in health and disease.Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.Inorganic phosphate-triggered release of anti-cancer arsenic trioxide from a self-delivery system: an in vitro and in vivo study.Phosphate handling by end-stage kidneys and benefits of residual renal function on phosphate removal in patients on haemodialysis.Phosphate removal model: an observational study of low-flux dialyzers in conventional hemodialysis therapy.FAM20C regulates osteoblast behaviors and intracellular signaling pathways in a cell-autonomous manner.Incisor enamel formation is impaired in transgenic rats overexpressing the type III NaPi transporter Slc20a1.Scientific Opinion on Dietary Reference Values for phosphorusTwo novel variants of the PHEX gene in patients with X‑linked dominant hypophosphatemic rickets and prenatal diagnosis for fetuses in these families.Downregulation of renal type IIa sodium-dependent phosphate cotransporter during lipopolysaccharide-induced acute inflammation.
P2860
Q21092419-94F597FB-A338-4CB4-A6A5-FC727992BC36Q26851904-D6D6AA9B-5E50-4D84-A3AD-5B56ED6C1668Q26853017-38FF8F3A-1A31-4CDE-9081-6E0E55F9EBAAQ27022049-1DA2668D-451A-4E81-B660-B35F71ED4078Q28265843-BC8CD1DB-4645-4A3E-8EAD-EE0DDF9DFCC1Q28275381-FE5FD6A1-9298-41C8-9ACE-0AF4432934DEQ28566881-6B9104E4-E1A5-40F1-8875-23A0E1645739Q30234616-AA14580D-ABB4-4FCF-B4F7-79B69977D0AEQ33999350-2C07D340-689E-4EDD-99EC-CDA547A677AEQ34130936-294A5ADB-8CEF-427B-B97B-0D1C5C3396D9Q35015899-9F06233F-AD88-4C14-9477-9E5F1DFEA025Q35140676-0A83D97B-0B8C-48EB-8294-4732C4ADF65CQ35167526-8362FB10-0118-4BE1-A2C8-2CB4FF2053C0Q36177303-461E962B-9346-4ABC-B820-E8AE6555CC6BQ36521099-E0D44EDF-105A-4253-A70B-7CE510498257Q36890341-ED0F1F6F-C4C4-4CB4-A65D-63324DF071E4Q37102306-F5E72E05-1712-4B8E-B58C-79D9A46EDB93Q37824821-91F4AF2D-1D36-469A-8091-A0E965D33DD4Q38050402-2836EFB4-B490-4834-BC6A-9DC07A91EC40Q38172416-2407EFF8-046E-4092-815C-414FFE4798BCQ38203228-D4768436-DAC4-4C2E-AE14-D6283FE442B2Q38222594-66BF5F8A-C65A-4E5A-9EA1-3732C735A9E3Q38571301-DABD9770-B020-4705-8EE3-A85EFB9F52C3Q38633258-51762374-30D5-402C-90CE-BDDA3B78DA9CQ38789790-846403E2-A33A-4DFC-9A32-027548FDA72FQ45344346-364585F0-1706-4E6D-9DB3-EB5A535284E4Q45901521-E09C37BF-D93E-4ED4-8A7D-64D546647ABAQ46274265-AF7683C5-0128-4147-87B8-4329585B9D68Q46293671-5E2127E9-DD57-4BB6-8F60-BD866FEDA290Q47157169-7F3BEDB5-F839-4C41-8257-A808D69D761EQ47547043-059743FD-1C3F-4752-9CFD-1579CCD1BF39Q54295582-6B98C2FE-171F-4A6C-941B-75B47ABFE956
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Recent advances in renal phosphate handling.
@ast
Recent advances in renal phosphate handling.
@en
Recent advances in renal phosphate handling.
@nl
type
label
Recent advances in renal phosphate handling.
@ast
Recent advances in renal phosphate handling.
@en
Recent advances in renal phosphate handling.
@nl
prefLabel
Recent advances in renal phosphate handling.
@ast
Recent advances in renal phosphate handling.
@en
Recent advances in renal phosphate handling.
@nl
P2860
P356
P1476
Recent advances in renal phosphate handling.
@en
P2093
Emily G Farrow
Kenneth E White
P2860
P2888
P304
P356
10.1038/NRNEPH.2010.17
P407
P577
2010-02-23T00:00:00Z